Otsuka Holdings Co., Ltd.: all 780 studies

Page 2 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 DisorderCompletedNCT04030143Phase 1/2Results posted
• A Study of TAS-120 in Patients With Metastatic Breast CancerTerminatedNCT04024436Phase 2Results posted
• Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral IntakeCompletedNCT03962101Phase 3Results posted
• Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic DermatitisCompletedNCT03961529Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03911401Phase 3Results posted
• Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndromeCompletedNCT03908970Phase 3Results posted
• Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mgCompletedNCT03902574Phase 1Results posted
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of SchizophreniaTerminatedNCT03896945Phase 2/3Results posted
• A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®TerminatedNCT03892889Phase 3Results posted
• Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active InflammationTerminatedNCT03850509Phase 2Results posted
• Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart FailureCompletedNCT03772041Phase 3Results posted
• A Long-Term Study of Brexpiprazole in Patients With Major Depressive DisorderCompletedNCT03737474Phase 3Results posted
• Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03724942Phase 3Results posted
• First in Human Study to Assess Safety of VIS649 in Healthy SubjectsCompletedNCT03719443Phase 1Results posted
• A Study of Brexpiprazole in Patients With Major Depressive DisorderCompletedNCT03697603Phase 2/3Results posted
• A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary TuberculosisCompletedNCT03678688Phase 1/2Results posted
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's DisorderTerminatedNCT03661983Phase 4Results posted
• A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive DisorderTerminatedNCT03643159Phase 4Results posted
• Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03620981Phase 2/3Results posted
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II HypertensionActive, not recruitingNCT03614260Not applicableResults posted
• A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT03605849Phase 3Results posted
• A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity DisorderCompletedNCT03605836Phase 3Results posted
• A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity DisorderCompletedNCT03605680Phase 3Results posted
• Guadecitabine Extension StudyTerminatedNCT03603964Phase 2Results posted
• A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03594123Phase 3Results posted
• A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
• A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03548584Phase 3Results posted
• A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive DisorderCompletedNCT03538691Phase 3Results posted
• Study of ASTX029 in Subjects With Advanced Solid TumorsCompletedNCT03520075Phase 1/2Results posted
• Phase I Study of OPC-61815CompletedNCT03510663Phase 1Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive DisorderTerminatedNCT03420222Phase 2Results posted
• Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male AdultsCompletedNCT03342963Phase 1Results posted
• The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity DisorderCompletedNCT03324581Phase 2Results posted
• Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AMLCompletedNCT03306264Phase 3Results posted
• Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of MigraineCompletedNCT03303105Phase 3Results posted
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic MigraineCompletedNCT03303092Phase 2/3Results posted
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic MigraineCompletedNCT03303079Phase 2/3Results posted
• A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.CompletedNCT03287869Phase 3Results posted
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I DisorderCompletedNCT03259555Phase 3Results posted
• A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I DisorderCompletedNCT03257865Phase 3Results posted
• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume OverloadCompletedNCT03255226Phase 3Results posted
• Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart FailureCompletedNCT03254108Not applicableResults posted
• Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With SchizophreniaCompletedNCT03238326Phase 3Results posted
• Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With SchizophreniaCompletedNCT03198078Phase 3Results posted
• Post-Marketing Surveillance Study of Aripiprazole in Patients With AutismCompletedNCT03179787Results posted
• Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.CompletedNCT03175029Phase 2Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain InjuryCompletedNCT03095066Phase 2Results posted
• A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHCompletedNCT03048747Phase 3Results posted
• Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza ACompletedNCT03040141Phase 2Results posted
• A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)CompletedNCT03033069Phase 2Results posted
• Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03018691Phase 2Results posted
• A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male SubjectsCompletedNCT02994394Phase 1Results posted
• Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza ACompletedNCT02989194Phase 2Results posted
• An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With SchizophreniaCompletedNCT02970929Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With SchizophreniaCompletedNCT02969382Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease PsychosisCompletedNCT02969369Phase 2Results posted
• Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)CompletedNCT02964273Phase 3Results posted
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid LeukemiaCompletedNCT02920008Phase 3Results posted
• Study of OPA-15406 Ointment in Patients With Atopic DermatitisCompletedNCT02914548Phase 2Results posted
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAsCompletedNCT02907359Phase 3Results posted
• Exploratory Trial of TAS-303 in Female Patients With Stress Urinary IncontinenceCompletedNCT02906683Phase 2Results posted
• Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3DCompletedNCT02900924Results posted
• Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male SubjectsCompletedNCT02875080Phase 1Results posted
• A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRCCompletedNCT02860546Phase 2Results posted
• A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1CompletedNCT02855125Phase 2Results posted
• Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKDCompletedNCT02847624Results posted
• A Phase IIa Study of TAS-205 for Duchenne Muscular DystrophyCompletedNCT02752048Phase 2Results posted
• Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine SystemCompletedNCT02722967Phase 2Results posted
• Samsca Post Marketing Surveillance StudyCompletedNCT02722863Results posted
• A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male SubjectsCompletedNCT02679469Phase 1Results posted
• A Study of the ReCor Medical Paradise System in Clinical HypertensionActive, not recruitingNCT02649426Not applicableResults posted
• A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683CompletedNCT02573350Phase 2Results posted
• Pharmacodynamic Study of Cilostazol in Healthy VolunteersCompletedNCT02554721Phase 1Results posted
• An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in SpainCompletedNCT02548845Results posted
• Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT02547428Phase 2Results posted
• An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADHCompletedNCT02545101Results posted
• Safety, Tolerability and Efficacy of AVP-786 for the Treatment of DisinhibitionTerminatedNCT02534038Phase 2Results posted
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric CancerCompletedNCT02500043Phase 3Results posted
• Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)TerminatedNCT02496039Phase 4Results posted
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual SchizophreniaCompletedNCT02477670Phase 2Results posted
• A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial EnteritisCompletedNCT02473393Phase 2Results posted
• International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic HyponatremiaCompletedNCT02449044Phase 3Results posted
• Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeTerminatedNCT02446132Phase 3Results posted
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's TypeCompletedNCT02442778Phase 3Results posted
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedNCT02442765Phase 3Results posted
• A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese SubjectsCompletedNCT02440633Phase 1Results posted
• A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic SchizophreniaTerminatedNCT02435836Phase 3Results posted
• Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)CompletedNCT02404532Phase 4Results posted
• Evaluation of Safety and Effectiveness of the BioMimics 3D Stent SystemCompletedNCT02400905Not applicableResults posted
• A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol DependenceCompletedNCT02382276Phase 3Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)CompletedNCT02364947Phase 3Results posted
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission InductionCompletedNCT02348489Phase 3Results posted
• A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male SubjectsCompletedNCT02334787Phase 1Results posted
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT02331680Phase 2Results posted
• Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric CancerCompletedNCT02322593Phase 3Results posted
• Phase 1 Study of SGI-110 in Patients With Acute Myeloid LeukemiaCompletedNCT02293993Phase 1Results posted
• A Phase I Study of TAS-102 in Solid TumorsCompletedNCT02261532Phase 1Results posted
• Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02251275Phase 3Results posted
• A Study of TAS-205 for Duchenne Muscular DystrophyCompletedNCT02246478Phase 1Results posted
• Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific CountriesCompletedNCT02223715Results posted

← Otsuka Holdings Co., Ltd. overview and focus areas